Alchemab Therapeutics

BiotechnologyLondon, UKalchemab.com

Latest round

—

Last raised

Oct 2026

Total raised

$121M

Investors

9

About Alchemab Therapeutics

Founded in 2019 in London, UK, Alchemab Therapeutics specializes in the development of antibody therapeutics.0 million.Alchemab Therapeutics specializes in the development of next-generation antibody therapeutics aimed at treating hard-to-manage diseases. The company's focus lies in leveraging the immune system's adaptive immunity to create therapeutics based on antibodies found in resilient individuals, such as long-term cancer survivors.Alchemab Therapeutics generates revenue through strategic partnerships and licensing agreements with major pharmaceutical companies. The company is focused on expanding its product offerings and is actively designing new therapeutics aimed at addressing diseases that lack effective treatments.

Who invested in Alchemab Therapeutics

9 investors across 5 rounds

See all investors in Alchemab Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Round

    Oct 16, 2026

    Amount

    $33M

    Investors

    Locked

  2. Series A

    Jul 3, 2025

    Amount

    $33M

    Investors

    Locked

  3. Series A

    Apr 15, 2021

    Amount

    $55M

    Investors

    Locked

  4. Seed

    Dec 1, 2019

    Amount

    Undisclosed

    Investors

    Locked

  5. Seed

    Jun 1, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Alchemab Therapeutics

Who invested in Alchemab Therapeutics?

Alchemab Therapeutics has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Alchemab Therapeutics raised?

Alchemab Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

What does Alchemab Therapeutics do?

Founded in 2019 in London, UK, Alchemab Therapeutics specializes in the development of antibody therapeutics.

Where is Alchemab Therapeutics headquartered?

Alchemab Therapeutics is headquartered in London, UK.

Which VCs invest in companies like Alchemab Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Alchemab Therapeutics's stage. Their profiles are linked below.

Raising like Alchemab Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.